CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,346 enrolled
Drug / intervention
nicotine patch +5 moredrug
Likely dose
nicotine patch 7 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00296647
NCT00296647Phase 4Completed
CompareCT.gov

Tobacco Dependence: Treatment and Outcomes; Pharmacotherapies: Effectiveness in Primary Care

University of Wisconsin, Madison·interventional·Posted Feb 27, 2006·Updated Oct 14, 2015

In Brief

A Phase 4 clinical trial evaluating nicotine patch, nicotine lozenge, and 3 other interventions for Tobacco Dependence. Completed, enrolled 1,346 participants across 1 site.

Detailed Summary

The information gathered in this study may help to develop more effective ways to help people quit smoking and stay quit in the future.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 27, 2006
Enrollment StartSep 1, 2004
Primary CompletionJul 1, 2009
Study CompletionDec 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 20.3 years ago

Interventions

nicotine patchdrug

Decreasing dosages from 21 to 7 mg over 12 week period

nicotine patchdrug

Decreasing dosage from 21 to 7 mg over 12 weeks

nicotine lozengedrug

4 mg nicotine lozenge: dosage according to package directions for 16 weeks

bupropiondrug

dosage according to prescription directions: 12 weeks

patch + lozengedrug

dosage of each according to package insert directions (12 weeks patch, 16 weeks lozenge)

bupropion + lozengedrug

dosage of each according to prescription or package insert (12 weeks bupropion, 16 weeks lozenge)